Top ▲
target has curated data in GtoImmuPdb
Target id: 3112
Nomenclature: nectin cell adhesion molecule 4
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 1 | 510 | 1q23.3 | NECTIN4 | nectin cell adhesion molecule 4 |
Previous and Unofficial Names |
Ig superfamily receptor LNIR | Nectin-4 | Nectin cell adhesion molecule 4 | Poliovirus receptor-related protein 4 | PVRL4 |
Database Links | |
Alphafold | Q96NY8 (Hs) |
ChEMBL Target | CHEMBL3712928 (Hs) |
Ensembl Gene | ENSG00000143217 (Hs) |
Entrez Gene | 81607 (Hs) |
Human Protein Atlas | ENSG00000143217 (Hs) |
KEGG Gene | hsa:81607 (Hs) |
OMIM | 609607 (Hs) |
Pharos | Q96NY8 (Hs) |
RefSeq Nucleotide | NM_030916 (Hs) |
RefSeq Protein | NP_112178 (Hs) |
UniProtKB | Q96NY8 (Hs) |
Wikipedia | NECTIN4 (Hs) |
Download all structure-activity data for this target as a CSV file
Antibodies | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immunopharmacology Comments |
Nectin 4 is the target of the immuno-oncology monoclonal antibody enfortumab vedotin, which was FDA approved in 2019 as a therapy for locally advanced/metastatic urothelial cancer that has been previously treated using a PD-1 or PD-L1 immune checkpoint inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting. |
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||||
|
General Comments |
Nectin 4 is a surface protein that participates in Ca2+-independent cell-cell adhesion. It is a component of adherens junctions, through interaction with the adaptor protein afadin (AFDN), which links it to the actin cytoskeleton. Nectin 4 is highly expressed in a wide range of solid tumours. The metalloproteinase ADAM17/TACE can cleave nectin 4's extracellular domain to create a secreted form. |
1. Brancati F, Fortugno P, Bottillo I, Lopez M, Josselin E, Boudghene-Stambouli O, Agolini E, Bernardini L, Bellacchio E, Iannicelli M et al.. (2010) Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome. Am J Hum Genet, 87 (2): 265-73. [PMID:20691405]
2. Jelani M, Chishti MS, Ahmad W. (2011) Mutation in PVRL4 gene encoding nectin-4 underlies ectodermal-dysplasia-syndactyly syndrome (EDSS1). J Hum Genet, 56 (5): 352-7. [PMID:21346770]
3. McGregor BA, Sonpavde G. (2019) Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma. Expert Opin Investig Drugs, 28 (10): 821-826. [PMID:31526130]
4. Upadhyaya P, Kristensson J, Lahdenranta J, Repash E, Ma J, Kublin J, Mudd GE, Luus L, Jeffrey P, Hurov K et al.. (2022) Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology. J Med Chem, 65 (14): 9858-9872. [PMID:35819182]
Immunoglobulin C2-set domain-containing proteins: nectin cell adhesion molecule 4. Last modified on 13/07/2022. Accessed on 11/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3112.